Join
Live feed
·
INSIDERFilingvia Quantisnow
Artiva Biotherapeutics Inc. logo

Chief Executive Officer Aslan Fred sold $690,392 worth of shares (61,888 units at $11.16), decreasing direct ownership by 4% to 1,473,194 units (SEC Form 4) (tax liability)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ARTV (Artiva Biotherapeutics Inc.) and more on Quantisnow.